• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: KYOWA MEDEX CO., LTD. (JAPAN) FOR: ADVIA CENTAUR XP INSULIN (IRI) ASSAY; INSULIN IMMUNOASSAY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

KYOWA MEDEX CO., LTD. (JAPAN) FOR: ADVIA CENTAUR XP INSULIN (IRI) ASSAY; INSULIN IMMUNOASSAY Back to Search Results
Model Number N/A
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 08/08/2016
Event Type  malfunction  
Manufacturer Narrative
The reagents were checked by the customer.There were no visible clumps.The quality control (qc) and the calibrations were acceptable.The field service engineer (fse) verified the hardware performance and found all data satisfactory.The field application specialist (fas) also performed other precision checks and sample correlations for the insulin (iri) assay.All the data was satisfactory.The cause for the discordant advia centaur xp insulin (iri) result is unknown.Pre- analytical factors may be the possible cause of the discordant result.The instrument is performing within specification.No further evaluation of the device is required.The ifu states on the interpretation of results: "results of this assay should always be interpreted in conjunction with patient's medical history, clinical presentation and other findings.".
 
Event Description
A falsely elevated advia centaur xp insulin (iri) result was obtained on a patient sample.The patient sample was repeated and the result was elevated.The physician sent the patient sample to another laboratory ((b)(6) lab) to be tested on an alternate platform.The result was lower.The same sample was tested at another location ((b)(6)) on the advia centaur xp and the result was similar to the alternate platform.The sample was then tested at the customer site on the advia centaur xp and the result was similar to the alternate platform.It is unknown if patient treatment was prescribed or altered.There was no report of adverse health consequences due to the insulin (iri) discordant results.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ADVIA CENTAUR XP INSULIN (IRI) ASSAY
Type of Device
INSULIN IMMUNOASSAY
Manufacturer (Section D)
KYOWA MEDEX CO., LTD. (JAPAN) FOR:
siemens healthcare diagnostics
511 benedict avenue
tarrytown NY 10591
Manufacturer (Section G)
SIEMENS HEALTHCARE DIAGNOSTICS, INC.
333 coney street
e. walpole MA 02032
Manufacturer Contact
eiman sulieman
333 coney street
e. walpole, MA 02032
5086604603
MDR Report Key5910301
MDR Text Key54276213
Report Number1219913-2016-00153
Device Sequence Number1
Product Code CFP
Combination Product (y/n)N
Reporter Country CodeIN
PMA/PMN Number
EXEMPT
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Reporter Occupation Other Health Care Professional
Remedial Action Inspection
Type of Report Initial
Report Date 08/29/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/29/2016
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date12/07/2016
Device Model NumberN/A
Device Catalogue Number02230141
Device Lot Number164
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received08/09/2016
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age27 YR
-
-